The Prostate Liquid Study (PLiS)
NCT04102904 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2020-03-26
Summary
A multi-site study to evaluate the potential use of the ChEC test of seminal fluid as an additional triage test in stratifying patients for further tests.
Conditions
Interventions
- OTHER
-
Observational
Patients will be asked to donate a semen sample which will be analysed and compared with their eventual diagnosis.
Sponsors & Collaborators
-
University College, London
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2021-03-31
- Completion
- 2021-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Precision Medicine in the Prostate Cancer Care Pathway
NCT04763317 ·Status: RECRUITING
-
Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer
NCT02198859 ·Status: COMPLETED ·Phase: PHASE1
-
Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients
NCT03408964 ·Status: RECRUITING
-
Measurements of Sexual Steroids' Concentrations in Prostatic Tissue
NCT04256161 ·Status: COMPLETED
-
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
NCT00959023 ·Status: UNKNOWN
-
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT02946996 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
NCT02381015 ·Status: COMPLETED ·Phase: NA
-
Prostate Nutrition and Exercise STudy (ProNEST)
NCT03173807 ·Status: WITHDRAWN ·Phase: NA
-
To Evaluate the Effect of MCS® in Prostate Cancer Prevention
NCT02042807 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prostatic Cancer Versus Androgen Deficiency
NCT02235142 ·Status: COMPLETED ·Phase: NA
-
In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies
NCT04873427 ·Status: TERMINATED
-
Cilengitide in Treating Patients With Prostate Cancer
NCT00121238 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
NCT03042468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
NCT02066961 ·Status: COMPLETED
-
Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate
NCT00006214 ·Status: COMPLETED ·Phase: PHASE2
-
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression
NCT04266431 ·Status: COMPLETED ·Phase: NA
-
Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer
NCT01530295 ·Status: UNKNOWN ·Phase: NA
-
Pioneering Advances in Care and Education (PACE)
NCT03397160 ·Status: COMPLETED ·Phase: NA
-
Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation
NCT03851211 ·Status: UNKNOWN
-
Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
NCT06070272 ·Status: NOT_YET_RECRUITING
-
Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer
NCT00006101 ·Status: COMPLETED ·Phase: PHASE2
-
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men
NCT00354497 ·Status: UNKNOWN ·Phase: PHASE2
-
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
NCT02217709 ·Status: COMPLETED ·Phase: PHASE2
-
Microbiome Molecular Charaterisation
NCT06423976 ·Status: RECRUITING
-
Liposomal Doxorubicin in Treating Patients With Prostate Cancer
NCT00004014 ·Status: COMPLETED ·Phase: PHASE2